Janus Biosciences Limited 15427252 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is scientific research. Digita Accounts Production Advanced 6.30.9574.0 true 15427252 2025-04-01 2026-03-31 15427252 2026-03-31 15427252 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 15427252 bus:Micro-entities 2025-04-01 2026-03-31 15427252 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 15427252 bus:FilletedAccounts 2025-04-01 2026-03-31 15427252 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 15427252 bus:RegisteredOffice 2025-04-01 2026-03-31 15427252 bus:Director1 2025-04-01 2026-03-31 15427252 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15427252 countries:AllCountries 2025-04-01 2026-03-31 15427252 2024-01-19 2025-03-31 15427252 core:CurrentFinancialInstruments core:WithinOneYear core:PreviouslyStatedAmount 2025-03-31 15427252 core:PreviouslyStatedAmount 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 15427252

Janus Biosciences Limited
Annual Report and Financial Statements
for the Year Ended 31 March 2026

Janus Biosciences Limited

Contents

Balance Sheet | 1 to 2

Janus Biosciences Limited

Company registration number: 15427252
Balance Sheet as at 31 March 2026

| 2026 £ | 2025 £
Current assets | 41,140 | 6,515
Creditors: Amounts falling due within one year | (51,215) | (5,470)
Total assets less current liabilities | (10,075) | 1,045
Accruals and deferred income | (1,286) | (1,174)
| (11,361) | (129)
Capital and reserves | (11,361) | (129)

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Approved and authorised by the director on 14 August 2026

Dr R K Johal Director

Janus Biosciences Limited

Company registration number: 15427252
Balance Sheet as at 31 March 2026 (continued)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
2nd Floor College House
17 King Edwards Road
Ruislip
LONDON
HA4 7AE

These financial statements were authorised for issue by the director on 14 August 2026.

2 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2025 - 1).